Leveraging AI to Close Care Gaps & Transform Patient Journeys: A Focus on HPP

Pangaea Data enters AI collaboration with Alexion to help improve detection of HPP in adults

Pangaea Data Secures Strategic Investment from Topcon Healthcare to Close Care Gaps in Eye Care

From Thin Ice to Solid Ground: How AI is Changing Clinical Practice for the Better

GO BACK

Pharmaceutical Success Stories

share this

Breakthrough AI to Characterize Hard to Diagnose Conditions to Find More Patients and Auto-Generate Regulatory Reports

Tuesday, November 16th at 12:00 PM EST (9:00 AM PT/ 5:00 PM GMT)

Hear from Dr. Rick Sax, former SVP at IQVIA, AstraZeneca and Merck, on how pharmaceutical companies are applying Pangaea’s novel AI for characterizing hard to diagnose diseases to find 95% more patients, improve screening success rates by 400% and save 80-90% time by automatically generating clinical narratives for regulatory reports.

Request Recording